Sputnik V shows efficacy against Covid-19-linked death in Hungarian study
Hungary
Astrocyte begins dosing in Phase I trial of traumatic brain injury therapy
The trial will evaluate multiple dose levels of AST-004 over six months at a clinical research site in Kistarcsa, Hungary.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox